In Glioma, XIST increases Rac-1 signaling by sequestering miR-137 [45], in colorectal cancer, it increases MAPK1 signaling by sequestering miR-132-3p [46] or by sequestering miR378, which targets MAPK1 in prostate. Here, RAC1 is linked to central nervous system cancer.